نتایج جستجو برای: brca1 و brca2

تعداد نتایج: 770130  

Journal: :Frontiers in oncology 2016
Jian Cui Jiangtao Luo Yeong C. Kim Carrie Snyder Dina Becirovic Bradley Downs Henry Lynch San Ming Wang

Ku80 is a subunit of the Ku heterodimer that binds to DNA double-strand break ends as part of the non-homologous end joining (NHEJ) pathway. Ku80 is also involved in homologous recombination (HR) via its interaction with BRCA1. Ku80 is encoded by the XRCC5 gene that contains a variable number tandem repeat (VNTR) insertion in its promoter region. Different VNTR genotypes can alter XRCC5 express...

Journal: :JAMA 2001
M C King S Wieand K Hale M Lee T Walsh K Owens J Tait L Ford B K Dunn J Costantino L Wickerham N Wolmark B Fisher

CONTEXT Among cancer-free women aged 35 years or older, tamoxifen reduced the incidence of estrogen receptor (ER)-positive but not ER-negative breast cancer. The effect of tamoxifen on breast cancer incidence among women at extremely high risk due to inherited BRCA1 or BRCA2 mutations is unknown. OBJECTIVE To evaluate the effect of tamoxifen on incidence of breast cancer among cancer-free wom...

Journal: :Human mutation 2000
U S Khoo H Y Ngan A N Cheung K Y Chan J Lu V W Chan S Lau I L Andrulis H Ozcelik

Germline mutations in the BRCA1 and BRCA2 genes predispose women to breast and ovarian cancer. An incidence of 5% and 3.3% respectively has been reported of BRCA1 and BRCA2 mutations in women with ovarian cancer unselected for family history. The contribution of BRCA1 and BRCA2 mutations to ovarian cancer in Chinese women is unknown. A total of 60 samples of ovarian cancer diagnosed in Chinese ...

Journal: :JAMA 2006
Tom Walsh Silvia Casadei Kathryn Hale Coats Elizabeth Swisher Sunday M Stray Jake Higgins Kevin C Roach Jessica Mandell Ming K Lee Sona Ciernikova Lenka Foretova Pavel Soucek Mary-Claire King

CONTEXT Genetic testing for inherited mutations in BRCA1 and BRCA2 has become integral to the care of women with a severe family history of breast or ovarian cancer, but an unknown number of patients receive negative (ie, wild-type) results when they actually carry a pathogenic BRCA1 or BRCA2 mutation. Furthermore, other breast cancer genes generally are not evaluated. OBJECTIVE To determine ...

Journal: :Cancer research 2012
Göran Jönsson Johan Staaf Johan Vallon-Christersson Markus Ringnér Sofia K Gruvberger-Saal Lao H Saal Karolina Holm Cecilia Hegardt Adalgeir Arason Rainer Fagerholm Camilla Persson Dorthe Grabau Ellinor Johnsson Kristina Lövgren Linda Magnusson Päivi Heikkilä Bjarni A Agnarsson Oskar T Johannsson Per Malmström Mårten Fernö Håkan Olsson Niklas Loman Heli Nevanlinna Rosa B Barkardottir Åke Borg

Breast tumors from BRCA1 germ line mutation carriers typically exhibit features of the basal-like molecular subtype. However, the specific genes recurrently mutated as a consequence of BRCA1 dysfunction have not been fully elucidated. In this study, we used gene expression profiling to molecularly subtype 577 breast tumors, including 73 breast tumors from BRCA1/2 mutation carriers. Focusing on ...

2018
Ye Xu Tao Ouyang Jinfeng Li Tianfeng Wang Zhaoqing Fan Tie Fan Benyao Lin Yuntao Xie

It is well known that BRCA1 and BRCA2 play a central role in DNA repair, but the relationship between BRCA1 and BRCA2 mRNA expression and response to neoadjuvant chemotherapy in sporadic breast cancer patients has not been well established. Here, we investigate the association between BRCA1 or BRCA2 mRNA expression levels and pathological response in 674 BRCA1/2 mutation-negative breast cancer ...

ژورنال: :genetics in the 3rd millennium 0
رکسانا مصلحی roxana moslehi وهرز غفاری vahraz ghaffari حسین نجم آبادی hossein najmabadi محمد حسن کریمی نژاد mohammad hassan kariminejad

اخیرا تعیین ژن های جهشی سندرم سرطان پستان و تخمدان در اقوام مختلفی گزارش و بر اهمین آن در پیشگیری از بروز بدخیمی تاکید شده است. به منظور بررسی ژن های جهشی این سندرم در جمعیت ایران و پیشگیری از بروز سرطان، از چند خانواده ایرانی که در بین آن ها سرطان های متعدد از قبیل مواردی از سرطان پستان و تخودان وجود داشت. پس از انجام مشاوره ژنتیک و تنظیم شجره نامه از مبتلایان و بستگان درجه اول آنها، نمونه گیر...

2013
Martin J. Larsen Torben A. Kruse Qihua Tan Anne-Vibeke Lænkholm Martin Bak Anne E. Lykkesfeldt Kristina P. Sørensen Thomas v. O. Hansen Bent Ejlertsen Anne-Marie Gerdes Mads Thomassen

Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of unclear pathogen significance are found in the families, constituting an increasing clinical chall...

Journal: :Sao Paulo medical journal = Revista paulista de medicina 2005
Rozany Mucha Dufloth Sílvia Carvalho Juliana Karina Heinrich Júlia Yoriko Shinzato César Cabello dos Santos Luiz Carlos Zeferino Fernando Schmitt

CONTEXT AND OBJECTIVE BRCA1 and BRCA2 are the two principal hereditary breast cancer susceptibility genes, and the prevalence of their mutations among Brazilian women is unknown. The objective was to detect BRCA1 and BRCA2 mutations in Brazilian patients with breast cancer, so as to establish genetic profiles. DESIGN AND SETTING Cross-sectional study, in Centro de Atenção Integral à Saúde da ...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014
Janet R Vos Natalia Teixeira Dorina M van der Kolk Marian J E Mourits Matti A Rookus Flora E van Leeuwen Margriet Collée Christi J van Asperen Arjen R Mensenkamp Margreet G E M Ausems Theo A M van Os Hanne E J Meijers-Heijboer Encarna B Gómez-Garcia Hans F Vasen Richard M Brohet Annemarie H van der Hout Liesbeth Jansen Jan C Oosterwijk Geertruida H de Bock

BACKGROUND We aimed to quantify previously observed relatively high cancer risks in BRCA2 mutation carriers (BRCA2 carriers) older than 60 in the Northern Netherlands, and to analyze whether these could be explained by mutation spectrum or population background risk. METHODS This consecutive cohort study included all known pathogenic BRCA1/2 carriers in the Northern Netherlands (N = 1,050). C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید